Single Drugs That 'Target' Tumor Cells Unlikely, In The Long Term, To Benefit Patients With Advanced Cancers
6/15/2012

Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns...

Pathway Determined For Origin Of Most Common Form Of Brain And Spinal Cord Tumor
6/15/2012

Johns Hopkins researchers say they have discovered one of the most important cellular mechanisms driving the growth and progression of meningioma, the most common form of brain and spinal cord tumor. A report on the discovery, published in the journal Molecular Cancer Research, could lead the way to the discovery of better drugs to attack these crippling tumors, the scientists say...

Patients With Lou Gehrig's Disease May Benefit From Cisplatin
6/15/2012

A long-used anti-cancer drug could be a starting point to develop new treatments for the incurable nerve disease known as Lou Gehrig's disease or amyotrophic lateral sclerosis (ALS), scientists are reporting. Their research showing how the drug prevents clumping of an enzyme linked to ALS appears in the Journal of the American Chemical Society...

Successful With New Immune Approach To Fighting Some Cancers
6/15/2012

A national research collaboration of senior researchers, including a researcher from Moffitt Cancer Center, has found that 20 to 25 percent of "heavily pre-treated" patients with a variety of cancers who enrolled in a clinical trial had "objective and durable" responses to a treatment with BMS-936558, an antibody that specifically blocks programmed cell death 1 (PD-1)...

Cancer Patient Attitudes To Clinical Trials Participation Changed By Multimedia Psychoeducational Intervention
6/15/2012

Seeking ways to change cancer patients' perceptions and negative attitudes towards clinical trials participation, researchers at Moffitt Cancer Center conducted a study offering two different kinds of intervention to two groups of adults with cancer who had not previously been asked to participate in clinical trials...

What Is HPV (Human Papilloma Virus)?
6/15/2012

HPV, or Human Papilloma Virus, is a virus from the papillomavirus family that affects human skin and the moist membranes that line the body, such as the throat, mouth, feet, fingers, nails, anus and cervix. There are over 100 types, of which 40 can affect the genital area. Most known HPV types cause no symptoms to humans...

What Is HPV (Human Papilloma Virus)? What Is The HPV Vaccine
6/15/2012

HPV, or Human Papilloma Virus, is a virus from the papillomavirus family that affects human skin and the moist membranes that line the body, such as the throat, mouth, feet, fingers, nails, anus and cervix. There are over 100 types, of which 40 can affect the genital area. Most known HPV types cause no symptoms to humans...

Cancer Survivors To Rise By A Third Over The Next Decade
6/15/2012

The American Cancer Society has released their latest addition to its facts and figures publication called "Cancer Treatment and Survivorship Facts & Figures"...

New Skin Cancer Drug Hailed As 'Greatest Advance Yet' By New England Journal Of Medicine
6/15/2012

Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine...

Lab-On-Chip Device Could Sort Cancer Cells
6/15/2012

In life, we sort soiled laundry from clean; ripe fruit from rotten. Two Johns Hopkins engineers say they have found an easy way to use gravity or simple forces to similarly sort microscopic particles and bits of biological matter - including circulating tumor cells...